Weight loss treatments have changed greatly in recent years, especially with the rise of drugs that target a hormone called GLP-1.
These medicines have been widely used because they can reduce appetite and help people lose weight.
However, they often come with side effects such as nausea, which can limit how much people can take and how well they tolerate the treatment.
A new study is now questioning whether GLP-1 is truly the most important target for weight loss.
The research was published in the journal Molecular Metabolism and offers a different way of thinking about how the body controls weight.
The study was led by researchers including Professor Richard DiMarchi from Indiana University Bloomington.
Instead of focusing on GLP-1, the team looked at two other hormones, GIP and glucagon. These hormones are also involved in how the body handles food, energy, and blood sugar levels.
The idea behind the study was simple but bold. What if removing GLP-1 from the equation could actually lead to better results? The researchers described this idea as “addition by subtraction.” In other words, by taking away one part of the system, they might find a better solution.
To explore this, they carried out experiments in animals, including mice, rats, and monkeys. In one key experiment, they used mice that did not have working GLP-1 receptors. This meant that the usual pathway targeted by many weight loss drugs was completely absent.
When these mice were given a new type of drug that targeted GIP and glucagon, they still lost weight. The amount of weight loss was similar to that seen in normal mice. This result showed that GLP-1 might not be essential for weight loss, as previously believed.
The researchers then tested how the hormones worked together. They found that targeting both GIP and glucagon at the same time led to greater weight loss than targeting either one alone. This suggests that the two hormones may work together in a powerful way to control appetite and energy use.
Another important finding was that the new treatment might increase how much energy the body burns. This means it could help people lose weight not only by eating less but also by using more energy.
The team also studied how safe the new approach might be. In experiments with monkeys, even high doses of the drug were well tolerated. The animals did not show signs of discomfort. In comparison, animals given existing GLP-1-based drugs could not handle higher doses as well.
This could be an advantage of the new approach, as it may allow for stronger treatment without increasing side effects. However, it is still too early to know if the same will be true in humans.
Experts who reviewed the study said the findings are impressive and provide a fresh perspective. They noted that it is important to explore different ways of understanding how the body regulates weight.
At the same time, there are important limitations. The study was done in animals, and human biology is more complex. Also, current GLP-1 drugs have been shown to improve heart health, which is a major benefit. It is not yet clear whether the new drugs will offer similar advantages.
This means that while the research is promising, it is only an early step. More studies will be needed to confirm the results and understand the full effects.
In summary, the study challenges a major assumption in weight loss science. It suggests that other hormone systems may be just as important as GLP-1. By exploring these alternatives, scientists may be able to develop new treatments that are more effective or easier to tolerate.
The findings encourage a broader view of how weight loss works. Instead of focusing on a single hormone, future treatments may involve multiple pathways working together.
Overall, this research adds valuable new knowledge. It does not replace current treatments, but it opens the door to new possibilities that could improve care in the future.
If you care about weight loss, please read studies that hop extract could reduce belly fat in overweight people, and early time-restricted eating could help lose weight .
For more health information, please see recent studies about a simple path to weight loss, and results showing a non-invasive treatment for obesity and diabetes.
